RT @CochraneIberoam: ¿Qué medicamento estimulante es mejor para los recién nacidos prematuros con apnea? En comparación con otras metilxan…
RT @CochraneIberoam: ¿Qué medicamento estimulante es mejor para los recién nacidos prematuros con apnea? En comparación con otras metilxan…
🤔🤔🤔🤔🤔
RT @CochraneIberoam: ¿Qué medicamento estimulante es mejor para los recién nacidos prematuros con apnea? En comparación con otras metilxan…
RT @CochraneIberoam: ¿Qué medicamento estimulante es mejor para los recién nacidos prematuros con apnea? En comparación con otras metilxan…
¿Qué medicamento estimulante es mejor para los recién nacidos prematuros con apnea? En comparación con otras metilxantinas, la cafeína podría dar lugar a una diferencia mínima o nula en la mortalidad y la duración de la estancia hospitalaria: https://t.c
RT @CochraneLibrary: 👶 Which common stimulant medicine is best for #premature #babies whose breathing pauses during sleep? #sleepapnea 📚 🔎…
RT @CochraneNeonate: New Review including 22 RCTs (1776 preterm infants), most of them on treatment of apnea (13 studies), the others on pr…
RT @CochraneNeonate: New Review including 22 RCTs (1776 preterm infants), most of them on treatment of apnea (13 studies), the others on pr…
👶 Which common stimulant medicine is best for #premature #babies whose breathing pauses during sleep? #sleepapnea 📚 🔎 @CochraneNeonate authors looked at the evidence from 22 studies with 1776 #preterm #newborns https://t.co/Bw75Z7OALY
RT @CochraneNeonate: New Review including 22 RCTs (1776 preterm infants), most of them on treatment of apnea (13 studies), the others on pr…
RT @neo_papers: Caffeine versus other methylxanthines for the prevention and treatment of apnea in preterm infants #neoTwitter https://t.co…
Caffeine versus other methylxanthines for the prevention and treatment of apnea in preterm infants #neoTwitter https://t.co/QaKsUDTtKI
Caffeine versus other methylxanthines for the prevention and treatment of apnea in preterm infants https://t.co/3Bu69HaTLs
RT @CochraneNeonate: New Review including 22 RCTs (1776 preterm infants), most of them on treatment of apnea (13 studies), the others on pr…
RT @CochraneNeonate: New Review including 22 RCTs (1776 preterm infants), most of them on treatment of apnea (13 studies), the others on pr…
RT @CochraneNeonate: New Review including 22 RCTs (1776 preterm infants), most of them on treatment of apnea (13 studies), the others on pr…
RT @CochraneNeonate: New Review including 22 RCTs (1776 preterm infants), most of them on treatment of apnea (13 studies), the others on pr…
RT @CochraneNeonate: New Review including 22 RCTs (1776 preterm infants), most of them on treatment of apnea (13 studies), the others on pr…
RT @CochraneNeonate: New Review including 22 RCTs (1776 preterm infants), most of them on treatment of apnea (13 studies), the others on pr…
RT @CochraneNeonate: New Review including 22 RCTs (1776 preterm infants), most of them on treatment of apnea (13 studies), the others on pr…
New Review including 22 RCTs (1776 preterm infants), most of them on treatment of apnea (13 studies), the others on prevention of apnea or extubation management. Mean gestational age 28 to 32 weeks. Read the findings: https://t.co/FLHBaNvMXh @AmerAcadPeds